By Rodolfo Valdés, Andres Tamayo, Marcos Gonzalez, Lamay Dorta, Jose Montero, Alejandro Figueroa, Eutimio Fernandez, Dobian Reveron, Yulian Mustelier, Hasel Aragon, Yanet Villega, Sigifredo Padilla, Leonardo Pasan, Deborah Geada, Aniel Sanchez, Vladamir Besada, Osvaldo Reyes, Yordanka Masforrol, Williams Ferro, Yenisley Medina, Jorge Lopez, Maylin La O, Lena Hernandez, Yurisleydi Aldama, Tatiana Gonzalez, Regla Somoza, Rosario Aleman, Enrique Noa, Gisela Calas, Cristina Garcia, Biunayki Reyes, Lorely Mila, and Ivvone Rodriguez
Volume 8, Issue 3 (Fall 2009)
Monoclonal antibodies (mAb) are highly selective molecules, and an unlimited amount of mAbs with equal quality can be produced using mammalian cell cultures and animals. These molecules have remarkable applications in biomedicine, diagnosis and therapy due to the ability to reproduce exactly the same binding properties. The mAbs have been generated against an ostensible set of compounds such as toxins, drugs, blood proteins, cancer cells, viruses, hormones, environmental pollutants, food products, metals and plant materials. In general, mAbs can also be used for creating sensitive tests to detect small amounts of substances, and in therapies, abzymes, and for isolating specific compounds from complex mixtures by immunoaffinity chromatography (IAC)…
Citation:
Valdés R et al. A Summary of the Manufacture, Biochemical Characterization, and Virological Safety Demonstration of the Mouse mAb CB.Hep-1 Used to Produce the Hepatitis B Vaccine. BioProcess J, 2009; 8(3): 13-31. https://doi.org/10.12665/J83.Valdes